These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9609998)
1. In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma. Sohda T; Iwata K; Soejima H; Kamimura S; Shijo H; Yun K J Hum Genet; 1998; 43(1):49-53. PubMed ID: 9609998 [TBL] [Abstract][Full Text] [Related]
2. Imbalance in expression levels of insulin-like growth factor 2 and H19 transcripts linked to progression of hepatocellular carcinoma. Iizuka N; Oka M; Tamesa T; Hamamoto Y; Yamada-Okabe H Anticancer Res; 2004; 24(6):4085-9. PubMed ID: 15736456 [TBL] [Abstract][Full Text] [Related]
3. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma]. Wu J; Qin Y; Li B; He WZ; Sun ZL Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726 [TBL] [Abstract][Full Text] [Related]
4. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Li X; Nong Z; Ekström C; Larsson E; Nordlinder H; Hofmann WJ; Trautwein C; Odenthal M; Dienes HP; Ekström TJ; Schirmacher P Cancer Res; 1997 May; 57(10):2048-54. PubMed ID: 9158004 [TBL] [Abstract][Full Text] [Related]
5. [VIGILIN involves in regulation of imprinting gene IGF2 and H19 in human hepatocellular carcinoma cell]. Ge YJ; Xie XY; Yang B; Chai XJ; Zhang YC; Qin Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):770-4. PubMed ID: 19950580 [TBL] [Abstract][Full Text] [Related]
6. Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma. Wu J; Qin Y; Li B; He WZ; Sun ZL Genomics; 2008 May; 91(5):443-50. PubMed ID: 18358696 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level. Sohda T; Yun K; Iwata K; Soejima H; Okumura M Lab Invest; 1996 Sep; 75(3):307-11. PubMed ID: 8804354 [TBL] [Abstract][Full Text] [Related]
8. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma]. Li H; Zhang N Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429 [TBL] [Abstract][Full Text] [Related]
9. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease. Takeda S; Kondo M; Kumada T; Koshikawa T; Ueda R; Nishio M; Osada H; Suzuki H; Nagatake M; Washimi O; Takagi K; Takahashi T; Nakao A; Takahashi T Oncogene; 1996 Apr; 12(7):1589-92. PubMed ID: 8622877 [TBL] [Abstract][Full Text] [Related]
10. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307 [TBL] [Abstract][Full Text] [Related]
11. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis. Vernucci M; Cerrato F; Besnard N; Casola S; Pedone PV; Bruni CB; Riccio A Oncogene; 2000 Dec; 19(54):6376-85. PubMed ID: 11175353 [TBL] [Abstract][Full Text] [Related]
12. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220 [TBL] [Abstract][Full Text] [Related]
13. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors. Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575 [TBL] [Abstract][Full Text] [Related]
14. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143 [TBL] [Abstract][Full Text] [Related]
15. Biallelic transcription of Igf2 and H19 in individual cells suggests a post-transcriptional contribution to genomic imprinting. Jouvenot Y; Poirier F; Jami J; Paldi A Curr Biol; 1999 Oct; 9(20):1199-202. PubMed ID: 10531031 [TBL] [Abstract][Full Text] [Related]
16. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Kim KS; Lee YI Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364 [TBL] [Abstract][Full Text] [Related]
17. Expression and imprinting of insulin-like growth factor II (IGF2) and H19 genes in uterine leiomyomas. Rainho CA; Pontes A; Rogatto SR Gynecol Oncol; 1999 Sep; 74(3):375-80. PubMed ID: 10479496 [TBL] [Abstract][Full Text] [Related]
18. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663 [TBL] [Abstract][Full Text] [Related]
19. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642 [TBL] [Abstract][Full Text] [Related]
20. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma. d'Arville CN; Nouri-Aria KT; Johnson P; Williams R Hepatology; 1991 Feb; 13(2):310-5. PubMed ID: 1847351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]